Antiepileptic Drugs (AEDs) and Kidney Stones 2

Project Title Antiepileptic Drugs (AEDs) and Kidney Stones 2
Date Posted
Tuesday, September 23, 2014
Project ID
MSY4_MPR55
Status
Complete
Deliverables
Description

Modular program-based one-time assessment of incidence of kidney stones following new use of anti-epileptic medications among all exposed patients and among those with a pre-existing condition of epilepsy and those with an exclusion of pre-existing anti-diabetic agent exposure. The query was run against the Mini-Sentinel Distributed Database (MSDD) for a time period of January 1, 2004 – December 31, 2012. Modular programs are adaptable standardized programs. Results were generated using Modular Program 3, version 5.0; click here for more information.  Queries were distributed in August 2013. This report includes data from 18 Data Partners.

If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to info@mini-sentinel.org.

The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

Medical Product
anti-epileptic drug (AED)
carbamazepine
gabapentin
lamotrigine
levetiracetam
oxcarbazepine
phenytoin
topiramate
valproic acid
zonisamide
Health Outcome
kidney stone
Time Period
January 1, 2004 - December 31, 2012
Assessment Type
Exploratory Analyses
Study Type
Modular Program
Data Sources
Mini-Sentinel Distributed Database (MSDD)
FDA Center
CDER